SEC Form D · filed January 27, 2025
Outlook Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Lawrence A. Kenyon · Iselin, NJExec · DirectorJeff R. Evanson · Iselin, NJExecRandy H. Thurman · Iselin, NJDirectorAndong G. Huang · Iselin, NJDirectorJulian G. Gangolli · Iselin, NJDirectorJulia A. Haller · Iselin, NJDirectorYezan H. Haddadin · Iselin, NJDirectorFaisal G. Sukhtian · Iselin, NJDirectorGerd G. Auffarth · Iselin, NJDirectorKurt J. Hilzinger · Iselin, NJDirectorMark H. Barineau · Houston, TXDirectorJames Bracken · Schaumburg, ILDirectorM. W. Macey, Jr · Greenwich, CTDirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorAlan Pierrot · Fresno, CADirectorJeff R. Evanson · Iselin, NJExecLuke Terrell · Fayetteville, ARDirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorJoseph J. Gault · Greenwich, CTDirectorMichael A. Barr · Greenwich, CTDirectorAvraham D. Dreyfuss · New York, NYDirectorMichael A. Scott · San Francisco, CADirectorAubrey Rankin · AUSTIN, TXDirectorDon Maniccia · AUSTIN, TXDirectorJared Hoffman · New York, NYDirectorNikolaos Perros · New York, NYDirectorLu Cai · New York, NYExec · DirectorXiao Jian Wang · New York, NYDirectorLei Zhang · New York, NYDirectorMartin Steyn · Grand Cayman, Cayman IslandsExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗